Form 8-K - Current report:
SEC Accession No. 0000950170-25-087369
Filing Date
2025-06-17
Accepted
2025-06-17 16:15:28
Documents
13
Period of Report
2025-06-13
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K crdf-20250613.htm   iXBRL 8-K 51906
2 EX-3.1 crdf-ex3_1.htm EX-3.1 123794
3 EX-99.1 crdf-ex99_1.htm EX-99.1 23663
4 GRAPHIC img186708884_0.jpg GRAPHIC 19987
  Complete submission text file 0000950170-25-087369.txt   356478

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT crdf-20250613.xsd EX-101.SCH 23903
15 EXTRACTED XBRL INSTANCE DOCUMENT crdf-20250613_htm.xml XML 4500
Mailing Address 11055 FLINTKOTE AVENUE SAN DIEGO CA 92121
Business Address 11055 FLINTKOTE AVENUE SAN DIEGO CA 92121 858-952-7570
Cardiff Oncology, Inc. (Filer) CIK: 0001213037 (see all company filings)

EIN.: 272004382 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35558 | Film No.: 251053481
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)